QUIPT HOME MEDICAL CORP (QIPT)
CA74880P1045 - Common Stock
Taking everything into account, QIPT scores 4 out of 10 in our fundamental rating. QIPT was compared to 115 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of QIPT while its profitability can be described as average. QIPT is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
QIPT had negative earnings in the past year.
In the past year QIPT had a positive cash flow from operations.
QIPT had negative earnings in 4 of the past 5 years.
Each year in the past 5 years QIPT had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -1.99%, QIPT perfoms like the industry average, outperforming 51.75% of the companies in the same industry.
The Return On Equity of QIPT (-4.53%) is comparable to the rest of the industry.
QIPT has a Return On Invested Capital (1.95%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.99% | ||
| ROE | -4.53% | ||
| ROIC | 1.95% |
ROA(3y)-1.07%
ROA(5y)-4.6%
ROE(3y)-2.35%
ROE(5y)-13.29%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 1.76%, QIPT is in line with its industry, outperforming 52.63% of the companies in the same industry.
QIPT's Operating Margin has improved in the last couple of years.
QIPT's Gross Margin of 73.60% is amongst the best of the industry. QIPT outperforms 92.11% of its industry peers.
QIPT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.76% | ||
| PM (TTM) | N/A | ||
| GM | 73.6% |
OM growth 3Y33.62%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.59%
GM growth 5Y1.35%
2. Health
2.1 Basic Checks
QIPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
QIPT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, QIPT has more shares outstanding
Compared to 1 year ago, QIPT has a worse debt to assets ratio.
2.2 Solvency
QIPT has an Altman-Z score of 0.74. This is a bad value and indicates that QIPT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.74, QIPT is doing worse than 64.91% of the companies in the same industry.
QIPT has a debt to FCF ratio of 2.96. This is a good value and a sign of high solvency as QIPT would need 2.96 years to pay back of all of its debts.
The Debt to FCF ratio of QIPT (2.96) is better than 83.33% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that QIPT is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.66, QIPT is in line with its industry, outperforming 49.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 2.96 | ||
| Altman-Z | 0.74 |
ROIC/WACC0.23
WACC8.33%
2.3 Liquidity
A Current Ratio of 1.11 indicates that QIPT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.11, QIPT is doing worse than 66.67% of the companies in the same industry.
A Quick Ratio of 0.77 indicates that QIPT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.77, QIPT is doing worse than 75.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
QIPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1200.00%.
The Revenue has grown by 28.34% in the past year. This is a very strong growth!
Measured over the past years, QIPT shows a very strong growth in Revenue. The Revenue has been growing by 32.15% on average per year.
EPS 1Y (TTM)-1200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)28.34%
Revenue growth 3Y45.08%
Revenue growth 5Y32.15%
Sales Q2Q%6.11%
3.2 Future
Based on estimates for the next years, QIPT will show a very strong growth in Earnings Per Share. The EPS will grow by 90.05% on average per year.
Based on estimates for the next years, QIPT will show a very strong growth in Revenue. The Revenue will grow by 20.77% on average per year.
EPS Next Y-34.06%
EPS Next 2Y59.8%
EPS Next 3Y44.54%
EPS Next 5Y90.05%
Revenue Next Year16.8%
Revenue Next 2Y10.5%
Revenue Next 3Y8.15%
Revenue Next 5Y20.77%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for QIPT. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 77.92, QIPT can be considered very expensive at the moment.
QIPT's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of QIPT to the average of the S&P500 Index (22.70), we can say QIPT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 77.92 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QIPT is valued cheaper than 99.12% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, QIPT is valued cheaply inside the industry as 98.25% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.93 | ||
| EV/EBITDA | 4.02 |
4.3 Compensation for Growth
QIPT's earnings are expected to grow with 44.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.8%
EPS Next 3Y44.54%
5. Dividend
5.1 Amount
QIPT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
QUIPT HOME MEDICAL CORP
NASDAQ:QIPT (10/17/2024, 8:59:34 PM)
After market: 3.02 0 (0%)3.02
-0.02 (-0.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap130.13M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 77.92 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.99% | ||
| ROE | -4.53% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 1.76% | ||
| PM (TTM) | N/A | ||
| GM | 73.6% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1200%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-34.06%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)28.34%
Revenue growth 3Y45.08%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y